跳至主要内容
临床试验/NCT05527106
NCT05527106已完成不适用

Evaluation of the Effect of Citicoline (Cebrolux 800 mg) and Docosahexaenoic Acid (DHA) Compound (BrudyPio 1.5 g) on the Visual Function of Patients With Glaucoma With a Pilot Study

Institut Catala de Retina1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2015年3月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
73
试验地点
1
主要终点
Effect on Visual Field Index (VFI)

研究概览

简要总结

Pilot, single-blind, randomized and controlled study to evaluate the changes produced in the visual function of patients with glaucoma after oral administration for 3 months of citicoline and docosahexaenoic Acid (DHA) vs citicoline and docosahexaenoic Acid (DHA) vs vitamin C.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with chronic, primary or secondary, open or closed angle glaucoma, diagnosed by meeting the following criteria:
  • •Signs of structural damage: thinning of the optical nerve or peripapillary hemorrhage or decrease in the nerve fiber layer that can be seen by OCT.
  • •Signs of functional damage: 3 points outside 95% of the normal limit on the visual field pattern deviation graph.
  • •There must be at least 3 reliable visual fields prior to the start of the study.
  • •Patients between 50 and 75 years old, homogeneously distributed among the groups.
  • •Glaucoma with functional and structural damage.
  • •Medium grade, Mean Deviation (MD) between -4 and -20 dB.
  • •In at least one eye.

排除标准

  • •Treatment with some other vitamin or nutraceutical preparation.
  • •Any pathology that can alter the visual field. (Neurological diseases, retinopathies, advanced cataract, patients treated with lyrica (due to the affectation it produces in the visual field)).
  • •Hypersensitivity to aspirin. (Cross-allergic reaction has been reported in patients taking citicoline.)
  • •Allergic to fish protein.
  • •Eye surgery in the 3 months before or during the study.

研究组 & 干预措施

Citicoline and Docosahexaenoic Acid (DHA)

Experimental

Cebrolux 800 and Brudypio 1.5g (see above).

干预措施: Citicoline and Docosahexaenoic Acid (DHA) (Dietary Supplement)

Docosahexaenoic Acid (DHA)

Experimental

Brudypio 1.5g is a food supplement based on Omega-3 fatty acid in the form of triglycerides (DHA 70% [350 mg], EPA 8.5%, DPA 6%) that also contains vitamins (A, B1, B2, B3, B6, B9, B12, C, E), carotenoids ( lutein, zeaxanthin, lycopene), glutathione, coenzyme Q10 and minerals (Zn, Se, Cu, Mn).

干预措施: Docosahexaenoic Acid (DHA) (Dietary Supplement)

Citicoline

Experimental

Cebrolux 800 is a food supplement based on citicoline (163 mg) that also contains vitamin A, E, C and B6.

干预措施: Citicoline (Dietary Supplement)

Vitamin C

Experimental

Vitamin C.

干预措施: Vitamin C (Dietary Supplement)

结局指标

主要结局

Effect on Visual Field Index (VFI)

时间窗: From Baseline to Month 3.

Evaluation of changes on the VFI (%) with study treatment.

Effect on Mean Defect (MD)

时间窗: From Baseline to Month 3.

Evaluation of changes on the MD (decibels) with study treatment.

次要结局

  • Evaluation of tolerance(From Month 1 to Month 3)
  • Evaluation of the changes produced in the intraocular pressure (IOP)(From Baseline to Month 3.)

研究者

发起方
Institut Catala de Retina
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验